# Evaluation of Depression Symptoms and Brain Activity Associated With Response to Treatment of Depression

> **NCT00200902** · PHASE4 · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 88 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** Venlafaxine (Effexor), Duloxetine (Cymbalta), Escitalopram (Lexapro)
- **OTHER:** Placebo
- **BEHAVIORAL:** Interpersonal Clinical Interaction (ICI)

## Key facts

- **NCT ID:** NCT00200902
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2024-08-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00200902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00200902, "Evaluation of Depression Symptoms and Brain Activity Associated With Response to Treatment of Depression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00200902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*